Pharmacy & Biological SciencesCategory
Digital ads for prescriptions are approaching parity with TV ads, with an even larger percentage of patients who saw ads online asking their doctors about specific medications.
Biopharma companies invested a total of $71.4 billion in research and development in 2017, up from $65.5 billion in 2016 and a record high.
Chris Collins, the United States Representative for New York’s 27th congressional district, has been arrested by the FBI on charges of insider trading.
Use of FDA-approved nicotine replacement therapy products may double the likelihood of a successful attempt to quit smoking.
Biopharma companies can balance competing demands from patients, investors, and regulators by keeping their focus on the science.
The task force is charged with identifying the reasons why some shortages remain a persistent challenge and to look for holistic solutions to addressing the underlying causes for these shortages.
Your best weapon to defeat the beast known as cancer is early detection. So, why is funding so focused on finding a “cure,” instead of screening?
An in-depth look at a recent paper that explores correlational data relating opioid prescribing to opioid manufacturer payments.
The increasing cost of Type 1 diabetes, one of the most common serious chronic diseases, has created heavy financial burdens for families, with insulin prices more than doubling in the past decade.
Take a look at highlights from 15 years of changes in biopharmaceutical manufacturing.